Changes in respiratory mechanics in myasthenia gravis with therapy. Counteracting effects of anticholinesterase.
D000293:Adolescent; D000328:Adult; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D004837:Epinephrine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D008168:Lung / Q000502:physiology; D008170:Lung Compliance / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000503:physiopathology*; D009388:Neostigmine / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D010313:Partial Pressure; D012119:Respiration / Q000187:drug effects; D012143:Respiratory Physiological Phenomena; D012137:Respiratory System / Q000187:drug effects*; D013147:Spirometry; D013566:Sympathomimetics / Q000627:therapeutic use; D014797:Vital Capacity
D002800:Cholinesterase Inhibitors; D010276:Parasympatholytics; D013566:Sympathomimetics; D009388:Neostigmine; D007545:Isoproterenol; D004837:Epinephrine